Terminal sugars of Fc glycans influence antibody effector functions of IgGs

被引:419
|
作者
Raju, T. Shantha [1 ]
机构
[1] Centocor R&D Inc, Discovery Res, Radnor, PA 19087 USA
关键词
D O I
10.1016/j.coi.2008.06.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IgG molecules contain glycans in the CH2 domain of the Fc fragment (N-glycosylation) which are highly heterogeneous, because of the presence of different terminal sugars. The heterogeneity of Fc glycans varies with species and expression system. Fc glycans influence the binding of IgG to Fc receptors and C1q, and are therefore important for IgG effector functions. Specifically, terminal sugars such as sialic acids, core fucose, bisecting N-acetylglucosamine, and mannose residues affect the binding of IgG to the Fc gamma RIIIa receptor and thereby influence ADCC activity. By contrast, terminal galactose residues affect antibody binding to C1q and thereby modulate CDC activity. Structural studies indicate that the presence or absence of specific terminal sugars may affect hydrophilic and hydrophobic interactions between sugar residues and amino acid residues in the Fc fragment, which in turn may impact antibody effector functions.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 50 条
  • [11] Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions
    Kellner, Christian
    Derer, Stefanie
    Valerius, Thomas
    Peipp, Matthias
    METHODS, 2014, 65 (01) : 105 - 113
  • [12] Regulation of antibody effector functions through IgG Fc N-glycosylation
    Isaak Quast
    Benjamin Peschke
    Jan D. Lünemann
    Cellular and Molecular Life Sciences, 2017, 74 : 837 - 847
  • [13] Regulation of antibody effector functions through IgG Fc N-glycosylation
    Quast, Isaak
    Peschke, Benjamin
    Lunemann, Jan D.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (05) : 837 - 847
  • [14] GLYCOSYLATION OF ANTIBODY MOLECULES PRODUCED INVITRO - RELEVANCE TO THE EXPRESSION OF FC EFFECTOR FUNCTIONS
    JEFFERIS, R
    LUND, J
    POUND, J
    GOODALL, M
    TYLER, R
    NASH, P
    TAKAHASHI, N
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A150 - A150
  • [15] Antibody Effector Functions Mediated by Fcγ-Receptors Are Compromised during Persistent Viral Infection
    Wieland, Andreas
    Shashidharamurthy, Rangaiah
    Kamphorst, Alice O.
    Han, Jin-Hwan
    Aubert, Rachael D.
    Choudhury, Biswa P.
    Stowell, Sean R.
    Lee, Junghwa
    Punkosdy, George A.
    Shlomchik, Mark J.
    Selvaraj, Periasamy
    Ahmed, Rafi
    IMMUNITY, 2015, 42 (02) : 367 - 378
  • [16] Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
    Cottignies-Calamarte, Andrea
    Tudor, Daniela
    Bomsel, Morgane
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [17] EXPLORING THE HIDDEN DIVERSITY OF FC RECEPTORS: UNRAVELING ANTIBODY EFFECTOR FUNCTIONS IN TELEOST FISH
    Chan, J. T. H.
    Kyslik, J.
    Meza, R. T. Montero
    Rebl, A.
    Koellner, B.
    Zlatina, K.
    Majstorovic, J.
    Korytar, T.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2023, 148
  • [18] The function of N-glycans attached to the Fc domain of IgGs in the progression of amyotrophic lateral sclerosis (ALS)
    Edri-Brami, Meital
    Barhum, Yael
    Offen, Daniel
    Lichtenstein, Rachel G.
    GLYCOBIOLOGY, 2013, 23 (11) : 1410 - 1410
  • [19] Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody
    Zhang, Di
    Goldberg, Monica V.
    Chiu, Mark L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (53) : 27134 - 27146
  • [20] Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
    DiLillo, David J.
    Ravetch, Jeffrey V.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (07) : 704 - 713